HIV-associated kidney diseases
https://doi.org/10.51523/2708-6011.2025-22-4-02
Abstract
The review reflects modern ideas of the variants of the course of kidney diseases in patients infected with human immunodeficiency virus (HIV): from HIV-associated nephropathy to chronic kidney disease (CKD). Such risk factors for the development of kidney diseases in HIV-infected patients as the level of immunosuppression, viral load, antiretroviral therapy, concomitant diseases were analyzed. Special attention has been given to the mechanisms of the pathogenesis of HIV-associated nephropathy and approaches to its diagnosis.
Taking into account the variety of morphological and clinical kidney lesions, we presented modern approaches to their early diagnosis.
About the Authors
K. S. Seudaleva
Gomel State Medical University
Беларусь
Беларусь
Kseniya S. Seudaleva - Assistant at the Department of Infectious Diseases, Gomel State Medical University.
Gomel
E. I. Kozorez
Gomel State Medical University
Беларусь
Беларусь
Elena I. Kozorez - Candidate of Medical Sciences, Associate Professor, Head of the Department of Infectious Diseases, Gomel State Medical University.
Gomel
I. O. Stoma
Gomel State Medical University
Беларусь
Беларусь
Igor O. Stoma - Doctor of Medical Sciences, Professor, Rector of Gomel State Medical University.
Gomel
References
1. Ekrikpo UE, Kengne AP, Bello AK, Effa EE, Noubiap JJ, Salako BL, et al. Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis. PLoS One. 2018;13(4):1-24. DOI: https://doi.org/10.1371/journal.pone.0195443
2. Nadkarni GN, Patel AA, Yacoub R, Benjo AM, Konstantinidis I, Annapureddy N, et al. The burden of dialysis-requiring acute kidney injury among hospitalized adults with HIV infection: a nationwide inpatient sample analysis. AIDS. 2015;29(9):1061-1066. DOI: https://doi.org/10.1097/QAD.0000000000000653
3. Rivera FB, Ansay MFM, Golbin JM, Alfonso PGI, Mangubat GFE, Menghrajani RHS, et al. HIV-Associated Nephropathy in 2022. Glomerular Disease. 2022;3(1):1-11. DOI: https://doi.org/10.1159/000526868
4. Swanepoel CR, Atta MG, D’Agati VD, Estrella MM, Fogo AB, Naicker S, et al. Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 2018;93(3):545-559. DOI: https://doi.org/10.1016/j.kint.2017.11.007
5. Naïke Bigé, Fanny Lanternier, Jean-Paul Viard, Prochore Kamgang, Eric Daugas, Caroline Elie, et al. Presentation of HIV-associated nephropathy and outcome in HAART-treated patients. Nephrology Dialysis Transplantation, 2012;27(3):1114-1121. DOI: https://doi.org/10.1093/ndt/gfr376
6. Volgina GV, Tomilina NA, Gadzhikulieva MM, Frolova NF. Glomerular kidney diseases in HIV-infection: Modern views on etiology, classification, pathogenesis. Nephrology and Dialysis. 2021;23(1):42-61. (In Russ.). DOI: https://doi.org/10.28996/2618-9801-2021-1suppl-42-61
7. Palau L, Menez S, Rodriguez-Sanchez J, Novick T, Delsante M, McMahon BA, et al. HIV-associated nephropathy: links, risks and management. HIV AIDS (Auckl). 2018;(10):73-81. DOI: https://doi.org/10.2147/HIV.S141978
8. Li J, Das JR, Tang P, Han Z, Jaiswal JK, Ray PE. Transmembrane TNF-α Facilitates HIV-1 Infection of Podocytes Cultured from Children with HIV-Associated Nephropathy. Journal of the American society of Nephrology. 2017;28(3):862-875. DOI: https://doi.org/10.1681/ASN.2016050564
9. Kasembeli AN, Duarte R, Ramsay M, Mosiane P, Dickens C, Dix-Peek T, et al. APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans. Journal of the American society of Nephrology. 2015;26(11):2882-2890. DOI: https://doi.org/10.1681/ASN.2014050469
10. Ashley-Koch AE, Okocha EC, Garrett ME, Soldano K, De Castro LM, Jonassaint JC, et al. MYH9 and APOL1 are both associated with sickle cell disease nephropathy. British Journal of Haematology. 2011;155(3):386-394. DOI: https://doi.org/10.1111/j.1365-2141.2011.08832.x
11. Yushchuk N.D, Gadzhikulieva MM, Volgina GV, Ivannikov EV, Frolova NF, Stolyarevich E.S. HIV-associated immune complex kidney disease. Infektsionnye Bolezni: Novosti, Mneniya, Obuchenie [Infectious Diseases: News, Opinions, Training]. 2020;9(2):57-62. (in Russ.). DOI: https://doi.org/10.33029/2305-3496-2020-9-2-57-62
12. Yushсhuk ND, Gadzhikulieva MM, Volgina GV, Zakharova EV, Stolyarevich ES. Thrombotic microangiopathy in patient with HIV-infection (сlinical observation). Infection Diseases News: Opinions. Training. Volume. 2016;16(3):107-112.
13. Franceschini N, Napravnik S, Eron JJ Jr, Szczech LA, Finn WF. Incidence and etiology of acute renal failure among ambulatory HIV-infected patients. Kidney International. 2005;67(4):1526-1531. DOI: https://doi.org/10.1111/j.1523-1755.2005.00232.x
14. Leonov IV, Puzyreva LV, Mordyk AV, Sitnikova SV, Antropova VV, et al. Multiorgan specific lesion at late stages of HIV infection. The Transbaikalian Medical Bulletin. 2017;(4):111-117. DOI: https://doi.org/10.52485/19986173_2017_4_111
15. Lioznov DA, Dunaeva NV, Chung NH, Gorchakova OV, Antonova TV. Chronic hepatitis C: modern condition of the problem. Nephrology (Saint-Petersburg). 2019;23(4):36-46. (In Russ.). DOI: https://doi.org/10.24884/1561-6274-2019-23-4-36-46
16. Mazzaro C, Adinolfi LE, Pozzato G, Nevola R, Zanier A, Serraino D, et al. Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy. Journal of Clinical Medicine. 2022;11(21):6247. DOI: https://doi.org/10.3390/jcm11216247
17. Rassokhin VV, Bobrovitskaya TM. Kidney lesions in HIV patients: epidemiology, approaches to classification, and principal clinical manifestations. Part 1. HIV Infection and Immunosuppression. 2018;10(1):25-36. (In Russ.). DOI: https://doi.org/10.22328/2077-9828-2018-10-1-25-36
18. Sethi S. The Changing Spectrum of Heroin-Associated Kidney Disease. Clinical Journal of the American Sociaty of Nephrology. 2018;13(7):975-976. DOI: https://doi.org/10.2215/CJN.06080518
19. Abraham AG, Althoff KN, Jing Y, Estrella MM, Kitahata MM, Wester CW, et al. North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis. 2015;60(6):941-949. DOI: https://doi.org/10.1093/cid/ciu919
20. Goryacheva OG. Chronic kidney disease in patients with chronic heart failure infected with human immunodeficiency virus. Medical alphabet. 2023;(25):26-32. (In Russ.). DOI: https://doi.org/10.33667/2078-5631-2023-25-26-31
21. Li F, Wang M, Wang J, Li R, Zhang Y. Alterations to the Gut Microbiota and Their Correlation with Inflammatory Factors in Chronic Kidney Disease. Frontiers in Cellular and Infection Microbiology. 2019;(9):206. DOI: https://doi.org/10.3389/fcimb.2019.00206
22. Prokopyeva NE, Novikova VP, Khavkin AI. Gut microbiota - kidney axis. Features in diseases of the urinary system and urogenital tract. Medicine: Theory and Practice. 2022;7(4):68-77. (In Russ.). DOI: https://doi.org/10.56871/MTP.2022.51.41.008
23. Rassokhin VV, Bobrovitskaya TM, Belyakov NA. Kidney lesions in HIV patients. Iatrogenic lesions and their diagnostics and treatment. Part 2. HIV Infection and Immunosuppressive Disorders. 2018;10(2):28-42. (In Russ.). DOI: https://doi.org/10.22328/2077-9828-2018-10-2-28-42
24. Kaboré NF, Poda A, Zoungrana J, Da O, Ciaffi L, Semdé A, et al. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting. BMC Nephrology. 2019;20(1):155. DOI: https://doi.org/10.1186/s12882-019-1335-9
25. Ryom L, Dilling Lundgren J, Reiss P, Kirk O, Law M, Ross M, et al. Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study. Journal Infection Disease. 2019;220(10):1629-1634. DOI: https://doi.org/10.1093/infdis/jiz369
26. Owako WO. Assessment of Tenofovir-Induced Nephrotoxicity Development and Recovery in HIV Patients on TDF Based Regimens at Kenyatta National Hospital Comprehensive Care Clinic. Clinical Journal HIV AIDS. 2020;6(1):76-84. [date of access 2025 June 15]. Available from: https://scholars.direct/Articles/hiv-and-aids/cjha-6-015.php?jid=hiv-and-aids
27. Bhimma R, Persadh K, Louansha N, Thagasveri N. Wcn24-140 the role of Β-2-microglobulin and cystatin c as urinary biomarkers in children with HIVAN. Kidney International Reports. 2024:4(9):132. DOI: https://doi.org/10.1016/j.ekir.2024.02.270
28. Naicker S, Dix-Peek T, Klar RM, Kalunga G, Mosiane P, Dickens C, et al. Profiling Biomarkers in HIV Glomerular Disease - Potential for the Non-Invasive Diagnosis of HIVAN? International Journal of Nephrology and Renovascukar Disease. 2021;14:427-440. DOI: https://doi.org/10.2147/IJNRD.S331484
29. Tereshkovets AS, Shibanova LA. Morphological characteristics of renal lesions in HIV infection. Life Sciences News. 2024;3(24):245-254. (In Russ.).
Review
For citations:
Seudaleva K.S., Kozorez E.I., Stoma I.O. HIV-associated kidney diseases. Health and Ecology Issues. 2025;22(4):14-21. (In Russ.) https://doi.org/10.51523/2708-6011.2025-22-4-02
Views:
10
JATS XML
Email this article 